miR-155 expression and function in leukemic stem cells
Garzon, R.; Croce, C. M.
Show abstract
It has been reported that elevated levels of miR-155 have been reported in patients with Acute Myeloid Leukemia (AML) bearing FLT3-ITD mutations and is independent of FLT3-ITD signaling. However, it is unclear how miR-155 is expressed in leukemic stem cells (LCS) and whether miR-155 has any role regulating LSC functions. In this manuscript, we defined the expression of miR-155 in clearly defined LCSs population and showed that miR-155 is regulating self-renewal and quiescence of LSCs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- ARPP19 promotes MYC expression and associates with patient relapse in acute myeloid leukemia 97%
- Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy 95%
- Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) using patient-derived induced pluripotent stem cells (iPSC) 95%
Similar papers in this journal
- Monosomy 7/del(7q) Cause Sensitivity to Inhibitors of Nicotinamide Phosphoribosyltransferase in Acute Myeloid Leukemia 95%
- Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia 95%
- Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications 92%
Similar papers in this journal
- Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations 94%
- BCR-ABL promotes hematopoietic stem and progenitor cell formation in embryonic stem cells 94%
- Endothelial protein C receptor CD201 is a better marker than SCA1 to identify mouse long-term reconstituting hematopoietic stem cells following septic challenge 92%
Similar papers in this journal
- DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes 94%
- Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core 94%
- Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors 94%
Similar papers in this journal
- STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia 95%
- Stratified computational meta-analysis of 2213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures 94%
- Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.